## Abstract Hepatitis C virus (HCV) subtypes were determined in 125 Iranian patients by phylogenetic analysis within the NS5B or 5′‐UTR/core regions. Subtypes 1a and 3a were predominant accounting for 47 and 36%, whereas 1b and 4 accounted for 8 and 7%. This subtype distribution differs from that o
Discrepancy of hepatitis C virus genotypes as determined by phylogenetic analysis of partial NS5 and core sequences
✍ Scribed by Yun, Zhibing; Lara, Claudia; Johansson, Bo; Lorenzana de Rivera, Ivette; Sönnerborg, Anders
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 475 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
The use of phylogenetic analyses of partial NS5 and core regions for hepatitis Cvirus (HCV) genotyping was evaluated by analysing seven Honduran and 24 European HCV strains. Core primers were designed with which HCV genotypes 1, 2, and 3 were readily amplified. The reliability of phylogenetic analysis of a 11 I-bp core sequence was verified by comparing the typing results with those obtained using the whole core gene of 52 reference strains. Accordant genotypes ( l a , 1 b, 2b. and 3a) were obtained when phylogenetic analyses were undertaken on both the partial core and a 222-bp NS5 sequence in all of the European HCV strains. Genotypes l a , Ib, and 3a were identified among the Honduran strains by phylogenetic analysis of the partial NS5 sequence. Interestingly, two of three Honduran type 3a strains, as determined by the NS5 sequence analysis, turned out to be type l a by core sequence analysis. These two strains were also classified as type l a , but not 3a, by a core typespecific PCR. Furthermore, the E2/NS1 regions were similar to HCV-PT, a representative strain of genotype l a . The results indicate that chimera1 HCV strains exist, although in most cases a good concordance is found when phylogenetic analysis of partial core and NS5 sequences are used
Methods
Patients Sera were obtained from eight anti-HCV positive patients in Honduras. Three patients were polytransfused (HO 2, HO 3, HO 4), two patients were detected in connection with blood donation (HO 1, HO 7), and three were prison inmates (HO 5, HO 6, HO 8). Twenty-four HCV strains from Sweden and Norway were also analysed together with the Honduran strains.
Reverse Transcription and PCR
HCV RNA was extracted from 100 p1 serum B u n et al., 19931 and subjected to a combined RT-PCR, using
📜 SIMILAR VOLUMES
## Abstract An effective vaccine is available for the hepatitis B virus (HBV), which is a very contagious human pathogen. The prevalence of chronic HBV infection is very low in the Netherlands (<0.5%), and no universal vaccination is in place. Instead, a program of vaccination for targeted groups a
## Abstract Glucose metabolism disturbances, including insulin resistance and type 2 diabetes, are frequent and important cofactors of hepatitis C. Increasing epidemiological and experimental data suggest that all major genotypes of hepatitis C virus (HCV), albeit to a different extent, cause insul
of patients with a high likelihood of response to IFN-b. In chronic hepatitis C virus (HCV) infection, geno-(HEPATOLOGY 1997;25:750-753.) types other than genotype 1b of HCV (HCV-1b) and low serum HCV-RNA levels are known to be associated with favorable outcome of interferon alfa (IFN-a) therapy. In
## Abstract The aim of the present study was to clarify the significance of viral factors for pretreatment prediction of sustained virological response to pegylated‐interferon (PEG‐IFN) plus ribavirin (RBV) therapy for chronic hepatitis C using data mining analysis. Substitutions in the IFN sensiti